Literature DB >> 1556191

Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.

Y J Geng1, G K Hansson.   

Abstract

The scavenger receptor (ScR) mediates uptake of chemically modified low density lipoprotein (LDL) by human monocyte-derived macrophages. It is not down-regulated by high intracellular cholesterol levels, and exposure of macrophages to acetylated or oxidized LDL therefore leads to foam cell development. The hypothesis that this represents an important mechanism for intracellular cholesterol accumulation in atherosclerosis is supported by the finding of ScR expression in foam cells of atherosclerotic plaques. T lymphocytes are also present in such plaques and it is known that T cell products regulate macrophage activation. We have therefore studied the effect of interferon-gamma (IFN gamma), a lymphokine secreted by activated T lymphocytes, on the expression of ScR in human monocyte-derived macrophages. Binding and uptake of acetylated LDL were significantly reduced in macrophages exposed to recombinant IFN gamma or IFN gamma-containing lymphocyte-conditioned media. Competition experiments showed that the IFN gamma-regulated binding and uptake of acetylated LDL was mediated via ScR. IFN gamma exerted its effect on the saturable binding of acetylated LDL by reducing the number of cell surface binding sites without significantly affecting the affinity between acetylated LDL and its receptor. Northern analysis revealed that the type I ScR mRNA was significantly reduced in IFN gamma-treated cells. Finally, IFN gamma treatment reduced intracellular cholesteryl ester accumulation and inhibited the development of foam cells in the cultures. In conclusion, our data show that IFN gamma blocks the development of macrophage-derived foam cells by inhibiting expression of ScR. This suggests that macrophage-T lymphocyte interactions may reduce intracellular cholesterol accumulation in the atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556191      PMCID: PMC442994          DOI: 10.1172/JCI115718

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

Review 1.  Molecular interactions in macrophage activation.

Authors:  D O Adams
Journal:  Immunol Today       Date:  1989-02

2.  Effects of activation on lipid and lipoprotein metabolism in murine macrophages.

Authors:  F B Kraemer; K Tavangar; R K Gandjei; K Kirlew; S R Behr
Journal:  Arteriosclerosis       Date:  1990 Jan-Feb

3.  Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II.

Authors:  L Rohrer; M Freeman; T Kodama; M Penman; M Krieger
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

4.  Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone.

Authors:  T Mokoena; S Gordon
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometers.

Authors:  R F Vogt; G D Cross; L O Henderson; D L Phillips
Journal:  Cytometry       Date:  1989-05

6.  Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma.

Authors:  L G Fong; T A Fong; A D Cooper
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

7.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

8.  An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors.

Authors:  M Freeman; J Ashkenas; D J Rees; D M Kingsley; N G Copeland; N A Jenkins; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1.

Authors:  D P Via; L Pons; D K Dennison; A E Fanslow; F Bernini
Journal:  J Lipid Res       Date:  1989-10       Impact factor: 5.922

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  52 in total

1.  Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.

Authors:  A E Horvai; L Xu; E Korzus; G Brard; D Kalafus; T M Mullen; D W Rose; M G Rosenfeld; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 2.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 3.  Class A1 scavenger receptors in cardiovascular diseases.

Authors:  Jingjing Ben; Xudong Zhu; Hanwen Zhang; Qi Chen
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

4.  Macrophage heterogeneity and cholesterol homeostasis: classically-activated macrophages are associated with reduced cholesterol accumulation following treatment with oxidized LDL.

Authors:  Eugene M Chu; Daven C Tai; Jennifer L Beer; John S Hill
Journal:  Biochim Biophys Acta       Date:  2012-11-08

5.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma.

Authors:  J LaMarre; B B Wolf; E L Kittler; P J Quesenberry; S L Gonias
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

Authors:  S Christen; S R Thomas; B Garner; R Stocker
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Authors:  Xindong Liu; Lilin Ye; Yu Bai; Habi Mojidi; Neil E Simister; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.